SEC Form 4 · accession 0001567619-19-005106
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea van Elsas
Officer — Chief Scientific Officer
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.88 | Feb 19, 2019 | A | 400,000 | A | — | Feb 18, 2029 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of February 19, 2019.